EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Edgewise Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$37.92+0.73 (+1.96%)
Close on Oct 19, 2026
- Market cap
- $4.08B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Edgewise Therapeutics has not reported a dividend
No dividend per share appears in Edgewise Therapeutics's annual filings since fiscal 2019.